ESMO survey on access to medicines
Dario Trapani, Medical Oncologist at the European Institute of Oncology, reshared a post by The European Society for Medical Oncology (ESMO) on X, adding:
“The European Society for Medical Oncology (ESMO) survey on Access to medicines describes and benchmarks the global situation on sustainable access to cancer medicines, to inform the development of cancer strategies toward health for all.”
Quoting The European Society for Medical Oncology (ESMO)’s post:
“ESMO is pleased to announce the publication of the ESMO Global Consortium Study on the availability, out-of-pocket costs, and accessibility of cancer medicines: 2023 update in January 2025.
Health For All.”
Dario Trapani is a medical oncologist at the European Institute of Oncology (IEO) and a researcher in the Department of Oncology and Hemato-oncology at the University of Milan. He previously served as a Postdoctoral Researcher at the Dana-Farber Cancer Institute and is focused on population health research.
More posts featuring Dario Trapani.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023